Evidence map›Paper›PMID 38698563›Full record

ArticleESC heart failure2024

Hyperlactataemia is a marker of reduced exercise capacity in heart failure with preserved ejection fraction.

Emilia Nan Tie, Emil Wolsk, Shane Nanayakkara, Donna Vizi, Justin Mariani, Jacob Eifer Moller, Christian Hassager, Finn Gustafsson, David M Kaye

Abstract read
In one paragraph

Article in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Lactate in Heart Failure.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emilia Nan TieDepartment of Cardiology, Alfred Hospital, Melbourne, VIC, 3004, Australia.ORCID 0000-0003-2728-7526
Emil WolskDepartment of Cardiology, Herlev-Gentofte Hospital, Copenhagen, Denmark.
Shane NanayakkaraDepartment of Cardiology, Alfred Hospital, Melbourne, VIC, 3004, Australia.
Donna ViziDepartment of Cardiology, Alfred Hospital, Melbourne, VIC, 3004, Australia.
Justin MarianiDepartment of Cardiology, Alfred Hospital, Melbourne, VIC, 3004, Australia.
Jacob Eifer MollerDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Christian HassagerDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Finn GustafssonDepartment of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
David M KayeDepartment of Cardiology, Alfred Hospital, Melbourne, VIC, 3004, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsHeart failure with preserved ejection fraction (HFpEF) is associated with an array of central and peripheral haemodynamic and metabolic changes. The exact pathogenesis of exercise limitation in HFpEF remains uncertain. Our aim was to compare lactate accumulation and central haemodynamic responses to exercise in patients with HFpEF, non-cardiac dyspnoea (NCD), and healthy volunteers. METHODS AND

resultsRight heart catheterization with mixed venous blood gas and lactate measurements was performed at rest and during symptom-limited supine exercise. Multivariable analyses were conducted to determine the relationship between haemodynamic and biochemical parameters and their association with exercise capacity. Of 362 subjects, 198 (55%) had HFpEF, 103 (28%) had NCD, and 61 (17%) were healthy volunteers. This included 139 (70%) females with HFpEF, 77 (75%) in NCD (P = 0.41 HFpEF vs. NCD), and 31 (51%) in healthy volunteers (P < 0.001 HFpEF vs. volunteers). The median age was 71 (65, 75) years in HFpEF, 66 (57, 72) years in NCD, and 49 (38, 65) years in healthy volunteers (HFpEF vs. NCD or volunteer, both P < 0.001). Peak workload was lower in HFpEF compared with healthy volunteers [52 W (interquartile range 31-73), 150 W (125-175), P < 0.001], but not NCD [53 W (33, 75), P = 0.85]. Exercise lactate indexed to workload was higher in HFpEF at 0.08 mmol/L/W (0.05-0.11), 0.06 mmol/L/W (0.05-0.08; P = 0.016) in NCD, and 0.04 mmol/L/W (0.03-0.05; P < 0.001) in volunteers. Exercise cardiac index was 4.5 L/min/m

conclusionsHFpEF is associated with reduced exercise capacity secondary to both central and peripheral factors that alter oxygen utilization. This results in hyperlactataemia. In HFpEF, plasma lactate responses to exercise may be a marker of haemodynamic and cardiometabolic derangements and represent an important target for future potential therapies.

Indexed as

BiomarkersExercise ToleranceHeart FailureStroke VolumeAgedCardiac CatheterizationExercise TestFemaleHumansLactic AcidMaleMiddle AgedVentricular Function, LeftBiomarkersLactic AcidCardiometabolicHeart failure with preserved ejection fractionLactate

Identifiers

PMID38698563
PMCPMC11424369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.